Bio-FD&C Co

Bio-FD&C Co OCF Margin

The Operating Cash Flow Margin of Bio-FD&C Co (251120.KQ) as of Nov 18, 2026 is 37.95 %. In the previous year, Operating Cash Flow Margin was 37.58 % — a change of 0.99% (higher).

OCF Margin

37.95 %

YoY

0.99%

Last updated:

Operating Cash Flow Margin of Bio-FD&C Co is 2025 37.95 % . Operating Cash Flow Margin of Bio-FD&C Co was 2024 37.58 % . It decreases by 0.99% higher compared to the previous year.

The Bio-FD&C Co OCF Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

OCF Margin
Date
OCF Margin
Jan 1, 2018
17.89 KRW
Jan 1, 2019
38.07 KRW
Jan 1, 2020
24.51 KRW
Jan 1, 2021
30.80 KRW
Jan 1, 2022
35.15 KRW
Jan 1, 2023
38.78 KRW
Jan 1, 2024
37.58 KRW
Jan 1, 2025
37.95 KRW
The Bio-FD&C Co OCF Margin history
YEAROCF MarginYoY
37.95 %+0.99%
37.58 %-3.10%
38.78 %+10.33%
35.15 %+14.14%
30.80 %+25.65%
24.51 %-35.62%
38.07 %+112.84%
17.89 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Bio-FD&C Co Stock analysis

What does Bio-FD&C Co do? Bio-FD&C Co., Ltd. develops bio and health technologies, focusing on manufacturing and selling soybean callus culture extract, clock stem cell, centella asiatica, callus extract, aloe barbadensis phytoplaceta extract, prunus mume phytoplacenta extract, secale cereale adventitious root extract, and acanthopanax koreanum adventitious root culture extract. These products serve as key materials for cosmeceuticals, health functional foods, and pharmaceuticals, targeting companies in the cosmetics, health supplement, and pharmaceutical industries. The company generates revenue through direct sales of these specialized extracts to manufacturers who incorporate them into their final products. The firm's product portfolio includes unique bioactive compounds like centella asiatica and prunus mume phytoplacenta extract, which are used in high-value applications within the cosmeceutical and pharmaceutical sectors. By supplying these specialized ingredients, Bio-FD&C Co., Ltd. caters to clients seeking natural, plant-based solutions for product development. Its focus on extract-based materials positions it as a supplier for companies developing innovative health and beauty products. Bio-FD&C Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bio-FD&C Co stock

Operating Cash Flow Margin of Bio-FD&C Co is 37.95 % in 2025.

Operating Cash Flow Margin of Bio-FD&C Co changed from 37.58 % to 37.95 %, representing a 0.99% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow Margin Bio-FD&C Co since 2006 – with annual values, charts, and detailed analysis.

OCF margin measures the percentage of revenue converted into operating cash flow. It indicates cash generation efficiency from core business operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Cash Flow Margin's Bio-FD&C Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Cash Flow Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Bio-FD&C Co

All Key Metrics — Bio-FD&C Co